EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway

H.-T. Fan; Y.-Y. Shi; Y. Lin; X.-P. Yang

European review for medical and pharmacological sciences (2019) - Comment
pubmed: 31599405 doi: 10.26355/eurrev_201909_18990 issn: 1128-3602 issn: 2284-0729

H.-T. Fan, Y.-Y. Shi, Y. Lin, X.-P. Yang

Go to article
Go to preprint

Verduci Editore s.r.l.